Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Advanced controlled transcranial magnetic stimulation to alleviate pain in diabetic neuropathy
EF 2023-24
Résumé
About 50% of diabetes patients face a complication called diabetic neuropathy, and within this population, ~20% develop painful diabetic neuropathy (pDN). pDN is the result of high glucose concentrations that damage the nerves in the brain and spinal cord, which leads these two areas to become excited. This increased excitability results in increased sensitivity to pain in the pDN population. Currently, the only treatment option is pharmacological managements, but these have serious side effects and are not the solution to reducing pain. Thus, it is important to find a novel way to treat neuropathic pain, such as the induction of neuroplasticity. Neuroplasticity refers to the ability of the brain to change, either through structural reorganization or functional changes in brain activation. This can be done non-invasively by using brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS), which delivers magnetic pulses to the brain. rTMS has been shown effectively to reduce pain in pDN. New advancements in rTMS technology called controlled pulse parameter TMS (cTMS) can produce larger and more long-lasting changes in neuroplasticity. In this study, the effects of a 10-day cTMS stimulation protocol in individuals with pDN will be assessed by investigating pain symptoms and assessing neurophysiology and somatosensory function. Individuals with pDN will be pseudo randomly allocated to either the ‘real’ or ‘sham’ cTMS condition and will take part in 10 days of stimulation over the course of two weeks. Then, they will cross-over to the opposite condition after a 2-month washout period and repeat the process. Since cTMS has not been explored in a pDN population, this cutting-edge study will present a novel, non-invasive treatment for pDN.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506510
Name
Park Jiyeon
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Advanced controlled transcranial magnetic stimulation to alleviate pain in diabetic neuropathy
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Controlled Pulse Parameter Transcranial Magnetic Simulation; Ctms; Neuropathic Pain; Neuroplasticity; Non Invasive Brain Stimulation; Pdn; Rtms
Abstract
About 50% of diabetes patients face a complication called diabetic neuropathy, and within this population, ~20% develop painful diabetic neuropathy (pDN). pDN is the result of high glucose concentrations that damage the nerves in the brain and spinal cord, which leads these two areas to become excited. This increased excitability results in increased sensitivity to pain in the pDN population. Currently, the only treatment option is pharmacological managements, but these have serious side effects and are not the solution to reducing pain. Thus, it is important to find a novel way to treat neuropathic pain, such as the induction of neuroplasticity. Neuroplasticity refers to the ability of the brain to change, either through structural reorganization or functional changes in brain activation. This can be done non-invasively by using brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS), which delivers magnetic pulses to the brain. rTMS has been shown effectively to reduce pain in pDN. New advancements in rTMS technology called controlled pulse parameter TMS (cTMS) can produce larger and more long-lasting changes in neuroplasticity. In this study, the effects of a 10-day cTMS stimulation protocol in individuals with pDN will be assessed by investigating pain symptoms and assessing neurophysiology and somatosensory function. Individuals with pDN will be pseudo randomly allocated to either the ‘real’ or ‘sham’ cTMS condition and will take part in 10 days of stimulation over the course of two weeks. Then, they will cross-over to the opposite condition after a 2-month washout period and repeat the process. Since cTMS has not been explored in a pDN population, this cutting-edge study will present a novel, non-invasive treatment for pDN.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Jiyeon
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~